Back to search

National and Kapodistrian University of Athens

Δημιουργία μοντέλου πρόβλεψης του κόστους στη ΜΕΘ, με κριτήριο τη βαρύτητα των νοσηλευόμενων ασθενών

Abstract

dc:description

Introduction: The cost of providing intensive care and support to critically ill patients in the ICU accounts for a significant proportion of total hospital costs. The calculation of the actual cost of hospitalized patients in the ICU is a necessary demand for the more efficient allocation of limited resources and the more effective and efficient reimbursement of hospitals.Objective: The purpose of the present study was twofold: on the one hand, to accurately determine the variable cost of hospitalized ICU patients, using the bottom-up costing methodology, and on the other hand, to find the degree of correlation of the APACHE II severity scale with the variable cost of hospitalization as well as the other determinants/variables that contribute to its final estimation.Methods: The present study is a retrospective observational study, which was carried out in the 7-bed ICU at 251 General Aviation Hospital, with a studied time period from January 1, 2016 to December 31, 2017. The total sample consisted of 204 medical (44.6%) and surgical (55 .4%) patients [122 females (59.8%) and 82 males (40.2%)] with different diagnoses, comorbidities, duration of hospitalization, disease severity, and necessity for mechanical ventilation (MV) and renal replacement therapy (RRT). In order to calculate the variable cost of ICU hospitalization, sex, age, reason for admission, duration of hospitalization, outcome, sepsis, severity of disease, duration of MV and RRT, as well as all laboratory/imaging tests, drugs and consumables were recorded by detail for each patient separately.Results: The mean age of the studied sample was 68.3 years (68.3 ± 16.1), with a mean length of stay (LOS) of 4.6 days (4.6 ± 3.9) and a mean APACHE II score equal to 24.46 (24.46 ± 9.81). Of the 204 patients, 62 died (mortality 30.4%). The most common reasons for ICU admission were Acute Respiratory Failure (36.4%), Gastrointestinal Diseases (15.7%), Central Nervous System Diseases (15.2%) and Lung Lobectomy (10.3 %). 42.2% of all patients had comorbidities, with Septic Shock (20.1%) and Acute Renal Failure (17.6%) being the most common. 73.5% of the studied sample was admitted to the ICU as an emergency, with 75.5% needing MV and 20% of them being supported with RRT. The mean daily total variable cost, the mean daily cost of laboratory/imaging tests, the mean daily cost of medication and the mean daily cost of consumables per patient were estimated € 787.2 ± €528.8, € 210.8 ± € 45, 302 .1 ± 341 € and € 420.8 ± 350.3 respectively. Of the total variable costs of the studied sample (€864,398.2486), 43.6% corresponded to the pharmaceutical expenditure, with the consumable’s cost and laboratory/imaging tests’ cost following, with percentages of 33% and 23.4% respectively. Medical patients (44.6% of the sample) showed almost twice average LOS (6.2 vs 3.4 days) and twice total variable cost (€578,812.4 vs €285,585.9) compared to surgical patients. The age group of VOPs (≥ 80 years) presented a higher average total cost (18-65 yrs: €732 vs 65-80 yrs: €757 vs VOPs: €910) compared to the age groups of 18-65 yrs and 65-80 yrs old. Additionally, 25% of the sample, developed sepsis, of which 57% were male and 69% of them were medical patients, with emergency admission to the ICU. Septic patients showed a higher APACHE II score than non-septic patients (33.1 vs 21.6), while their ICU’s costs were three times higher than other patients. 20% of the study sample underwent renal replacement therapy (CVVHDF), with 61% of the consumable’s cost related to the cost of consumables necessary to perform CVVHDF, highlighting it as one of the most expensive interventions performed in the ICU. Multivariable linear regression showed a statistically significant relationship between the APACHE II severity scale and the variable cost of ICU hospitalization (coefficient b=0.027, 95% CI=0.022 to 0.032, p<0.001). Apart from the APACHE II scale, other main determinants of costs, which emerged from the multivariable prediction equation, were the type of patient (medical/surgical), length of stay, age and renal replacement therapy. From the comparison of the actual total variable cost and the amount of compensation received by the hospital, a shortfall of €203,272 emerged, with the compensation covering 76.8% of the actual total variable cost of ICU hospitalization.Conclusion: Almost half of total variable ICU cost is due to pharmaceutical costs. Medical, septic patients, with a high APACHE II score and under renal replacement therapy show the most costly ICU stay and the highest rate of underfunding. The strong positive correlation between the disease severity and variable cost should be considered in health policy making.Key words: ICU cost, top – down costing methodology, bottom – up costing methodology, DRG’s, reimbursement

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Mastrogianni, Maria
  • Μαστρογιάννη, Μαρία

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54241

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mastrogianni, Maria; Μαστρογιάννη, Μαρία. Δημιουργία μοντέλου πρόβλεψης του κόστους στη ΜΕΘ, με κριτήριο τη βαρύτητα των νοσηλευόμενων ασθενών. National and Kapodistrian University of Athens, 2023. http://hdl.handle.net/10442/hedi/54241